Removal of ARR is consistent with the redefinition of revenues. Last qtr they had revenues of $10.3m which would have made for a 36% decrease instead of the reported 3%. Agree it's underwhelming but we are at least moving to consistent definitions which can be compared to on a like for like basis. The problem with the reporting of "revenues" for this company though is that companies tend to prepay services so that they can get certainty of their costs for the year. But dubber isn't allowed to report some of that prepayment as revenue until "the performance obligation is satisfied".
- Forums
- ASX - By Stock
- DUB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
-0.001(3.33%) |
Mkt cap ! $26.85M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.9¢ | $24.34K | 834.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 448519 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 1062519 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 448519 | 0.029 |
8 | 632129 | 0.028 |
4 | 241500 | 0.027 |
1 | 400000 | 0.026 |
3 | 230039 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 1062519 | 6 |
0.031 | 117144 | 3 |
0.032 | 39932 | 2 |
0.033 | 42496 | 1 |
0.034 | 119357 | 1 |
Last trade - 15.45pm 10/10/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online